Back to search
FDAFDA · Food and drugs·Recall number D-0222-2018

Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15.

Published January 24, 2018 · Recall initiated: January 3, 2018

Summary

FDA records drug Class II recall D-0222-2018, published January 24, 2018 and initiated January 3, 2018. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 237 cartons; Lot: Lot: 15270, Exp. 01/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Nationwide in the USA
Lot
Lot: 15270, Exp. 01/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15. recalled?

Yes. FDA published recall D-0222-2018 on January 24, 2018. Reported hazard: Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter